HealthCare Markets Group
HealthCare Markets Group identifies itself as a healthcare advisory and investment banking firm with healthcare advisory, specialized healthcare investment banking, and finance operating units. Its publicly listed coverage spans healthcare providers and healthcare technology, while its M&A services include seller and buyer representation, valuation, transaction-process support, and financing-related work.
What stands out about HealthCare Markets Group
HealthCare Markets Group publicly describes a healthcare-focused advisory and investment banking platform based in Houston, Texas. It states that it works with assignments regardless of transaction size, supports both confidential negotiated sales and publicly announced auction processes, and lists representative transactions; the dates of those examples are not provided on its official investment-banking portfolio page.[1][2][3][4][5]
What does HealthCare Markets Group do?
HealthCare Markets Group identifies itself as a healthcare advisory and investment banking firm with its corporate office in Houston, Texas. It states that its platform includes healthcare advisory, specialized healthcare investment banking, and finance operating units.[1]
Publicly stated services include strategic market studies, specialized research projects, strategic alliances, joint ventures, licensing-agreement structuring, and business-plan development. The firm also states that it assists with acquisitions, management buyouts, corporate restructurings, joint ventures, start-ups, divestitures, and equity-investment partner searches.
Its valuation practice covers recapitalizations, acquisitions, divestitures, mergers, ESOPs, stock redemptions, and partnership buyouts.[2][3][4]
Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.
What should a business owner evaluate before hiring HealthCare Markets Group?
An owner evaluating HealthCare Markets Group can clarify how the firm’s healthcare coverage, buyer qualification, valuation support, process design, negotiation assistance, definitive-agreement support, and closing assistance would apply to the contemplated transaction. The firm’s public materials describe both publicly announced auction processes and confidential private negotiated sales.
The official investment-banking portfolio page does not provide dates for its listed representative transactions, and many transaction-information fields are marked not disclosed. The About Us page does not state the legal entity or firm-level regulatory registration number or status. These points warrant direct confirmation when evaluating an engagement.[1][3][5]
Which transactions listed by the firm have closed within the last three years, and can the firm provide dates, transaction values, buyer identities, and seller references
What legal entity would sign the engagement letter, and what regulatory or licensing framework applies to the proposed services
How would the firm structure a confidential private negotiated sale or a publicly announced auction process for the contemplated transaction
What size transactions and clients does HealthCare Markets Group focus on?
The firm’s publicly listed healthcare coverage includes acute-care hospitals, ambulatory surgery centers, cancer treatment centers, LTAC facilities, home healthcare, rehabilitation, assisted living, sleep labs, managed care, laboratory services, and diagnostic imaging. Its healthcare-technology coverage includes healthcare information services, monitoring, cardiac products, catheters, orthopedic products, PACS and teleradiology, lasers, surgical instruments, and pharmaceuticals.[1]
The official investment-banking portfolio lists HealthCare Markets Group as exclusive financial advisor to Hologic, Inc. in Hologic’s acquisition of Direct Radiography Corp., with transaction information of $20,000,000. It also lists the firm as special advisor to VS&A Communications Partners III, L.P. in its acquisition of HCIA, Inc., with transaction information of $130,000,000.
Another listed example is the sale of El Paso Cancer Treatment Center to Physician Reliance Network, for which HealthCare Markets Group states that it served as exclusive financial advisor, with transaction information of $11,500,000.[5]
HealthCare Markets Group states that it supports acquisitions, divestitures, management buyouts, corporate restructurings, joint ventures, and equity-investment partner searches. Its publicly described work also includes valuation analyses and financing-related advisory services.[3][4]
What does HealthCare Markets Group publicly disclose about fees, process and engagement terms?
The official investment-banking portfolio page lists representative transactions but does not provide transaction dates for the listed examples. The same page marks many transaction-information fields as not disclosed.
The official About Us page identifies the firm and its operating units but does not state a legal-entity name or a firm-level regulatory registration number or status.[1][5]
The official About Us page describes HealthCare Markets Group as having healthcare advisory, specialized healthcare investment banking, and finance units, with a corporate office in Houston, Texas.
That page does not state a legal-entity name or a firm-level regulatory registration number or regulatory status.[1]
For sellers, the firm states that it can support publicly announced auction processes and confidential private negotiated sales. Its stated process support includes buyer qualification, valuation analysis, price and terms negotiation, definitive-agreement support, and closing assistance.[3]
Questions to ask before hiring HealthCare Markets Group
Which transactions listed by the firm have closed within the last three years, and can the firm provide dates, transaction values, buyer identities, and seller references?
What legal entity would sign the engagement letter, and what regulatory or licensing framework applies to the proposed services?
How would the firm structure a confidential private negotiated sale or a publicly announced auction process for the contemplated transaction?
Which healthcare subsectors and international buyer relationships would be covered by the proposed engagement?
Who would lead the engagement, and what are the proposed fee structure, expense policy, exclusivity, termination rights, tail period, and conflicts procedures?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Services / capabilities
- Services / capabilities
- Transaction / portfolio evidence
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.